Literature DB >> 25569408

Comparison of different administration of ketamine and intravenous tramadol hydrochloride for postoperative pain relief and sedation after pediatric tonsillectomy.

Alper Yenigun1, Tayfun Et, Sirin Aytac, Betul Olcay.   

Abstract

OBJECTIVES: Tonsillectomy is the oldest and most frequently performed surgical procedure practiced by ear, nose, and throat physicians. In this study, our aim was to compare the analgesic effects of peritonsillar, rectal, as well as intravenous infiltration of ketamine and intravenous tramadol hydrochloride infiltration for postoperative pain relief and sedation after tonsillectomy in children.
MATERIALS AND METHODS: This randomized controlled study evaluated the effects of peritonsillar, intravenous, and rectal infiltration of ketamine in children undergoing adenotonsillectomy. One hundred twenty children who were categorized under American Society of Anesthesiologists classes I to II were randomized to 4 groups of 30 members each. Group 1 received intravenous (IV) ketamine (0.5 mg/kg), group 2 received rectal ketamine (0.5 mg/kg), group 3 received local peritonsillar ketamine (2 mg/kg), and the control group received IV tramadol hydrochloride infiltration (2 mg/kg). Children's Hospital of Eastern Ontario Pain Scale scores and Wilson sedation scale were recorded at minutes 1, 15, 30, 60 as well as hours 2, 12, and 24 postoperatively. The patients were interviewed on the day after the surgery to assess the postoperative pain and sedation.
RESULTS: All the routes of infiltration of ketamine were as effective as those of tramadol hydrochloride (P > 0.05). A statistically significant difference was observed between IV infiltrations and all groups during the assessments at hours 6 and 24. The analgesic efficacy of IV ketamine was found especially higher at hours 6 and 24 (P(6) = 0.045, P(24) = 0.011).
CONCLUSIONS: Perioperative, low-dose IV, rectal, or peritonsillar ketamine infiltration provides efficient pain relief without any adverse effects in children who would undergo adenotonsillectomy.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25569408     DOI: 10.1097/SCS.0000000000001250

Source DB:  PubMed          Journal:  J Craniofac Surg        ISSN: 1049-2275            Impact factor:   1.046


  6 in total

1.  [Interdisciplinary position paper "Perioperative pain management"].

Authors:  R Likar; W Jaksch; T Aigmüller; M Brunner; T Cohnert; J Dieber; W Eisner; S Geyrhofer; G Grögl; F Herbst; R Hetterle; F Javorsky; H G Kress; O Kwasny; S Madersbacher; H Mächler; R Mittermair; J Osterbrink; B Stöckl; M Sulzbacher; B Taxer; B Todoroff; A Tuchmann; A Wicker; A Sandner-Kiesling
Journal:  Schmerz       Date:  2017-10       Impact factor: 1.107

2.  Comparing local anesthetic infiltration of the peritonsillar region and glossotonsillar sulcus for post-tonsillectomy pain management.

Authors:  Nur Yücel Ekici; Hatice Özdoğan
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-09-28       Impact factor: 2.503

3.  Comparison of single-dose nalbuphine versus tramadol for postoperative pain management in children: a randomized, controlled trial.

Authors:  Naeem Liaqat; Sajid Hameed Dar
Journal:  Korean J Anesthesiol       Date:  2016-11-25

4.  The comparison of ketamine with tramadol for postoperative pain relief on children following adenotonsillectomy or tonsillectomy: A meta-analysis of randomized controlled trials.

Authors:  Lifeng Wang; Yongkang Guo; Jun Tian
Journal:  Medicine (Baltimore)       Date:  2021-04-09       Impact factor: 1.817

5.  Effect of Subanaesthetic Dose of Ketamine on Pneumoperitoneal Response and Clinical Recovery in Patients Undergoing Laparoscopy.

Authors:  Swaminathan Veerasamy Rajarajan; Arun Kumar Alarasan; Anand Subramaniam; Lailu Mathews
Journal:  Turk J Anaesthesiol Reanim       Date:  2022-06

Review 6.  When the Safe Alternative Is Not That Safe: Tramadol Prescribing in Children.

Authors:  Frédérique Rodieux; Laszlo Vutskits; Klara M Posfay-Barbe; Walid Habre; Valérie Piguet; Jules A Desmeules; Caroline F Samer
Journal:  Front Pharmacol       Date:  2018-03-05       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.